These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26762338)

  • 41. Performance of large- and small-volume valved holding chambers with a new combination long-term bronchodilator/anti-inflammatory formulation delivered by pressurized metered dose inhaler.
    Nagel MW; Wiersema KJ; Bates SL; Mitchell JP
    J Aerosol Med; 2002; 15(4):427-33. PubMed ID: 12581509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aerodynamic deposition of combination dry powder inhaler formulations in vitro: a comparison of three impactors.
    Taki M; Marriott C; Zeng XM; Martin GP
    Int J Pharm; 2010 Mar; 388(1-2):40-51. PubMed ID: 20026261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pressure Drop Characteristics of the Reduced NGI Configuration with Several Common Glass Fiber Filters.
    Roberts DL
    J Aerosol Med Pulm Drug Deliv; 2023 Apr; 36(2):82-88. PubMed ID: 36897321
    [No Abstract]   [Full Text] [Related]  

  • 45. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations.
    Mitchell JP; Nagel MW
    J Aerosol Med; 2003; 16(4):341-77. PubMed ID: 14977427
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploring the impact of sample flowrate on in vitro measurements of metered dose inhaler performance.
    Lewis DA; O'Shea H; Church TK; Brambilla G; Traini D; Young PM
    Int J Pharm; 2016 Dec; 514(2):420-427. PubMed ID: 27210737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
    Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
    Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterisation of solution-based pressurised metered-dose inhaler aerosols with an optical particle counter.
    Kuhli M; Weiss M; Steckel H
    Eur J Pharm Biopharm; 2010 Aug; 75(3):393-8. PubMed ID: 20347974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aerodynamic dose emission characteristics of dry powder inhalers using an Andersen Cascade Impactor with a mixing inlet: the influence of flow and volume.
    Yakubu SI; Assi KH; Chrystyn H
    Int J Pharm; 2013 Oct; 455(1-2):213-8. PubMed ID: 23892154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved quality control metrics for cascade impaction measurements of orally inhaled drug products (OIPs).
    Tougas TP; Christopher D; Mitchell JP; Strickland H; Wyka B; Van Oort M; Lyapustina S
    AAPS PharmSciTech; 2009; 10(4):1276-85. PubMed ID: 19882251
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacopeial methodologies for determining aerodynamic mass distributions of ultra-high dose inhaler medicines.
    Wong W; Crapper J; Chan HK; Traini D; Young PM
    J Pharm Biomed Anal; 2010 Mar; 51(4):853-7. PubMed ID: 19932579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.
    Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP
    Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterisation of high dose aerosols from dry powder inhalers.
    Grasmeijer F; Hagedoorn P; Frijlink HW; de Boer AH
    Int J Pharm; 2012 Nov; 437(1-2):242-9. PubMed ID: 22939966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design and pharmaceutical applications of a low-flow-rate single-nozzle impactor.
    Wang H; Bhambri P; Ivey J; Vehring R
    Int J Pharm; 2017 Nov; 533(1):14-25. PubMed ID: 28939463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro comparison of the effect of inhalation delay and flow rate on the emitted dose from three valved holding chambers.
    Slator L; von Hollen D; Sandell D; Hatley RH
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27 Suppl 1():S37-43. PubMed ID: 24476047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A methodology to study impactor particle reentrainment and a proposed stage coating for the NGI.
    Rissler J; Asking L; Dreyer JK
    J Aerosol Med Pulm Drug Deliv; 2009 Dec; 22(4):309-16. PubMed ID: 19415989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The in vitro and in vivo investigation of inhaled migraine therapies using a novel aerosol delivery system consisting of an air pressurized capsule device (APCD) in combination with a pMDI spacer for endotracheal dosing into beagle dogs.
    Sellers S; Horodnik W; House A; Wylie J; Mauser P; Garber N; Pu YE; Berry J; Donovan B
    Drug Dev Ind Pharm; 2015; 41(12):1989-96. PubMed ID: 25986873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dissolution of fine particle fraction from truncated Anderson cascade impactor with an enhancer cell.
    Tay JYS; Liew CV; Heng PWS
    Int J Pharm; 2018 Jul; 545(1-2):45-50. PubMed ID: 29689370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part II: Archival calibration.
    Marple VA; Olson BA; Santhanakrishnan K; Mitchell JP; Murray SC; Hudson-Curtis BL
    J Aerosol Med; 2003; 16(3):301-24. PubMed ID: 14572327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of inspiratory profiles from patients with chronic obstructive pulmonary disease (COPD) to investigate drug delivery uniformity and aerodynamic dose emission of indacaterol from a capsule based dry powder inhaler.
    Abadelah M; Chrystyn H; Larhrib H
    Eur J Pharm Sci; 2019 Jun; 134():138-144. PubMed ID: 31005623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.